Direct-to-Patient Models Prompt Pharmaceutical Manufacturers to Reassess Distribution Strategies

Laura Blair has addressed the evolving dynamics of pharmaceutical distribution, highlighting how direct-to-patient (DTP) models are prompting manufacturers to reassess traditional access and distribution strategies. Her insights shed light on the growing intersection between virtual fulfillment methods and conventional pharmacy systems.

Blair emphasized that DTP models, which deliver medications directly to patients’ homes, are reshaping how manufacturers approach supply chains and patient access. These models offer an alternative to traditional pharmacy-based distribution by streamlining delivery processes and potentially improving convenience for patients. However, she noted that this shift requires careful consideration of logistical challenges, regulatory compliance, and patient engagement strategies. Blair’s discussion underscores the need for manufacturers to adapt their frameworks in response to these emerging trends while balancing innovation with established practices.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI